Thursday, February 25, 2021
- Advertisement -

TAG

TCO stock

Taubman Centers Inc. [TCO] gain 37.57% so far this year. What now?

Taubman Centers Inc. price surged by 0.02 percent to reach at $0.01. The company report on November 24, 2020 that WeissLaw LLP Reminds...

Taubman Centers Inc. [TCO] Revenue clocked in at $585.70 million, up 26.99% YTD: What’s Next?

Taubman Centers Inc. jumped around 2.07 points on Friday, while shares priced at $39.48 at the close of the session, up 5.53%. The...

Taubman Centers Inc. [TCO] moved down -1.43: Why It’s Important

Taubman Centers Inc. closed the trading session at $33.71 on 09/23/20. The day’s price range saw the stock hit a low of $33.22,...

Taubman Centers Inc. [TCO] moved up 0.70: Why It’s Important

Taubman Centers Inc. closed the trading session at $37.40 on 06/17/20. The day’s price range saw the stock hit a low of $36.515,...

Piper Sandler slashes price target on Taubman Centers Inc. [TCO] – find out why.

Taubman Centers Inc. closed the trading session at $36.17 on 06/10/20. The day’s price range saw the stock hit a low of $26.70,...

Latest news

Lowe’s Companies Inc. [LOW] moved down -3.73: Why It’s Important

Lowe's Companies Inc. closed the trading session at $162.31 on 02/24/21. The day’s price range saw the stock hit a low of $160.11,...

why Regulus Therapeutics Inc. [RGLS] is a Good Choice for Investors After New Price Target of $1.33

Regulus Therapeutics Inc. slipped around -0.08 points on Wednesday, while shares priced at $1.39 at the close of the session, down -5.44%. The...

Applied Materials Inc. [AMAT] Stock trading around $122.81 per share: What’s Next?

Applied Materials Inc. stock went on an upward path that rose over 5.74% on Wednesday, amounting to a one-week price increase of more...

Ashford Hospitality Trust Inc. [AHT] is 53.28% higher this YTD. Is it still time to buy?

Ashford Hospitality Trust Inc. price surged by 5.87 percent to reach at $0.22. The company report on January 25, 2021 that Cygnus Capital...

VistaGen Therapeutics Inc. [VTGN] Revenue clocked in at $0.60 million, up 21.65% YTD: What’s Next?

VistaGen Therapeutics Inc. loss -5.22% or -0.13 points to close at $2.36 with a heavy trading volume of 3510854 shares. The company report...
- Advertisement -

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.